Literature DB >> 8250812

Endothelial and leukocyte activation in experimental polytrauma and sepsis.

H Redl1, A Nikolai, R Kneidinger, G Schlag.   

Abstract

Vascular endothelial-PMN interactions are critical reactions in the development of organ failure. Both cell types are activated by LPS and proinflammatory cytokines in sepsis. Reactions that are collectively referred to as endothelial activation include expression of procoagulant activity and increased adhesiveness of the endothelium for leukocytes. Some parameters, which are related to endothelial activation are significantly changed during sepsis and altered by anti-TNF therapy (e.g. PAI-1, thrombomodulin), while others (e.g. sELAM) are increased by sepsis but not influenced by anti-TNF therapy. Leukocyte activation (accompanied by elastase release) leads to rearrangement of the CD11/CD18 structures and thereby increased adherence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250812

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  4 in total

1.  Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production.

Authors:  M Ogata; T Matsui; T Kita; A Shigematsu
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances.

Authors:  W Schmidt; A Walther; M M Gebhard; E Martin; H Schmidt
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

3.  Lipopolysaccharide and interferon-gamma enhance Fas-mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression.

Authors:  N Koide; A Morikawa; G Tumurkhuu; J Dagvadorj; F Hassan; S Islam; Y Naiki; I Mori; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

4.  A non-lethal traumatic/hemorrhagic insult strongly modulates the compartment-specific PAI-1 response in the subsequent polymicrobial sepsis.

Authors:  Pierre Raeven; Alma Salibasic; Susanne Drechsler; Katrin Maria Weixelbaumer; Mohammad Jafarmadar; Martijn van Griensven; Soheyl Bahrami; Marcin Filip Osuchowski
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.